(MENAFN- PR Newswire) DUBLIN, Nov. 17, 2022 /PRNewswire/ -- The 'computer-aided drug discovery market by type, by therapeutic area, by end user: global opportunity analysis and industry forecast, 2021-2030' report has been added to
ResearchAndMarkets.com's offering.
The global computer-aided drug discovery market was valued at $2,940.9 million in 2021 and is projected to reach $7,504.7 million by 2030, growing at a CAGR of 11.48% from 2022 to 2030. The prevalence of chronic diseases, such as cardiovascular disease, has risen dramatically in recent years. According to the World Health Organization (WHO), the United Nations (UN) specialized agency responsible for international public health, the number of CVD patients may reach 23 million by the end of 2030. Furthermore, according to Premier, Inc., a notable healthcare improvement company, the demand for novel drugs for the treatment of CVD conditions has skyrocketed as a result of the COVID-19 crisis. The facts and figures presented above show that the need for the development of new drug molecules is expected to rise, which may have a positive impact on the global computer-aided drug discovery market during the analysis period.However, lack of skilled labor for operating computer aided drug discovery solutions may hamper the global market growth. Also, lower product penetration in the emerging economies is also restraining the global computer-aided drug discovery market.Emerging concepts such as artificial intelligence (AI) and big data in computer-aided drug discovery, on the other hand, may drive the market over the forecast period. Many aspects of drug discovery can benefit from artificial intelligence, including drug design, chemical synthesis, drug screening, drug repurposing, and polypharmacology.The global computer-aided drug discovery market is segmented on the basis of type, therapeutic area, end-user, and region. By type, the market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. By therapeutic area, the analysis has been divided into oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. By end-user, the market has been divided into pharmaceutical companies, biotechnology companies and research laboratories. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.The key players profiled in this report include BOCSCI Inc., Bioduro-Sundia, Schrodinger, Inc., Aragen Life Sciences Pvt. Ltd., Aris Pharmaceuticals, Inc, Charles River Laboratories, Bayer AG, AstraZeneca, and Albany Molecular Research Inc. (AMRI).
Key Market Segments By Type
Structure Based Drug Design Ligand-Based Drug Design Sequence-Based Approaches
By Therapeutic Area
Oncology Neurology Cardiovascular Disease Respiratory Disease Diabetes Others
By End User
Pharmaceutical Companies Biotechnology Companies Research Laboratories
By Region
North America U.S. Canada Mexico Europe Germany United Kingdom France Spain Italy Rest of Europe Asia-Pacific China Japan India South Korea Australia Rest Of Asia Pacific LAMEA Brazil Saudi Arabia UAE South Africa Rest of LAMEA
Key Market Players
charles river laboratories BOC Sciences Bioduro-Sundia Schrodinger, Inc. Aragen Life Sciences Pvt. Ltd. Aris Pharmaceuticals, Inc. Bayer AG AstraZeneca plc Albany Molecular Research Inc. (AMRI)
Key Topics Covered: CHAPTER 1: INTRODUCTION CHAPTER 2: EXECUTIVE SUMMARY CHAPTER 3: MARKET OVERVIEW CHAPTER 4: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY TYPE CHAPTER 5: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA CHAPTER 6: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY END USER CHAPTER 7: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY REGION CHAPTER 8: COMPANY LANDSCAPE CHAPTER 9: COMPANY PROFILES
For more information about this report visit
Media Contact:
Research and MarketsLaura Wood, Senior Manager[email protected]
For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
Logo:
SOURCE Research and Markets